This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Potassium carbonate
- DrugBank Accession Number
- DB13977
- Background
Potassium carbonate (K2CO3) is a white salt, soluble in water (insoluble in ethanol) which forms a strongly alkaline solution. It can be made as the product of potassium hydroxide's absorbent reaction with carbon dioxide. It presents a large capacity to absorb moisture.
- Type
- Small Molecule
- Groups
- Approved
- Structure
Structure for Potassium carbonate (DB13977)
- Weight
- Average: 138.2055
Monoisotopic: 137.912157588 - Chemical Formula
- CK2O3
- Synonyms
- Carbonate of potash
- Carbonic acid, dipotassium salt
- Dipotassium carbonate
- Kaliumcarbonat
- Potash, sulfurated
- Potassium carbonate
- Potassium carbonate, anhydrous
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
Indication Type Indication Combined Product Details Approval Level Age Group Patient Characteristics Dose Form Used in combination to treat Fungal skin infection Combination Product in combination with: Octasulfur (DB09353) •••••••••••• •••••••• Used in combination to treat Parasitic skin infections Combination Product in combination with: Octasulfur (DB09353) •••••••••••• •••••••• Used in combination to treat Psoriasis Combination Product in combination with: Octasulfur (DB09353) •••••••••••• •••••••• Used in combination to treat Seborrheic dermatitis Combination Product in combination with: Octasulfur (DB09353) •••••••••••• •••••••• - Associated Therapies
- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAcebutolol Potassium carbonate may increase the hyperkalemic activities of Acebutolol. Aceclofenac Potassium carbonate may increase the hyperkalemic activities of Aceclofenac. Acemetacin Potassium carbonate may increase the hyperkalemic activities of Acemetacin. Acetylsalicylic acid Potassium carbonate may increase the hyperkalemic activities of Acetylsalicylic acid. Alclofenac Potassium carbonate may increase the hyperkalemic activities of Alclofenac. - Food Interactions
- No interactions found.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Active Moieties
Name Kind UNII CAS InChI Key Carbonate ion ionic 7UJQ5OPE7D 3812-32-6 BVKZGUZCCUSVTD-UHFFFAOYSA-L - International/Other Brands
- Racol
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image Cleaning-S Liquid 0.1 g/100mL Topical Naro, Inc. 2018-01-02 Not applicable US 
Face-body-S Liquid 0.1 g/100mL Topical Naro, Inc. 2018-01-02 Not applicable US Food-S Liquid 0.1 g/100mL Oral; Topical Naro, Inc. 2018-01-02 Not applicable US Greenfish, Body-S Liquid 0.001 1/80mL Topical Kotuku Inc. 2016-04-07 Not applicable US Greenfish, Cleaning-S Liquid 0.001 1/450mL Topical Kotuku Inc. 2016-03-28 Not applicable US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Buffered Vitamin C Powder With Ca Mg and K Potassium carbonate (19.8 mg / g) + Ascorbic acid (470 mg / g) + Calcium carbonate (70 mg / g) + Magnesium carbonate (70 mg / g) Powder Oral Thorne Research Inc. 1997-04-18 2005-06-21 Canada 
Vit C W Calc-mag and Potass Powder Potassium carbonate (21.06 mg / g) + Ascorbic acid (500 mg / g) + Calcium carbonate (95.75 mg / g) + Magnesium oxide (53.2 mg / g) Powder, for solution Oral Nf Formulas Inc. 1986-12-31 2000-07-05 Canada - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Cleaning-S Potassium carbonate (0.1 g/100mL) Liquid Topical Naro, Inc. 2018-01-02 Not applicable US Face-body-S Potassium carbonate (0.1 g/100mL) Liquid Topical Naro, Inc. 2018-01-02 Not applicable US Food-S Potassium carbonate (0.1 g/100mL) Liquid Oral; Topical Naro, Inc. 2018-01-02 Not applicable US Greenfish, Body-S Potassium carbonate (0.001 1/80mL) Liquid Topical Kotuku Inc. 2016-04-07 Not applicable US Greenfish, Cleaning-S Potassium carbonate (0.001 1/450mL) Liquid Topical Kotuku Inc. 2016-03-28 Not applicable US
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as organic carbonic acids. These are compounds comprising the carbonic acid functional group.
- Kingdom
- Organic compounds
- Super Class
- Organic acids and derivatives
- Class
- Organic carbonic acids and derivatives
- Sub Class
- Organic carbonic acids
- Direct Parent
- Organic carbonic acids
- Alternative Parents
- Carbonate salts / Organic potassium salts / Organic oxides / Hydrocarbon derivatives / Carbonyl compounds
- Substituents
- Aliphatic acyclic compound / Carbonate salt / Carbonic acid / Carbonyl group / Hydrocarbon derivative / Organic alkali metal salt / Organic oxide / Organic oxygen compound / Organic potassium salt / Organic salt
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- BQN1B9B9HA
- CAS number
- 584-08-7
- InChI Key
- BWHMMNNQKKPAPP-UHFFFAOYSA-L
- InChI
- InChI=1S/CH2O3.2K/c2-1(3)4;;/h(H2,2,3,4);;/q;2*+1/p-2
- IUPAC Name
- dipotassium carbonate
- SMILES
- [K+].[K+].[O-]C([O-])=O
References
- General References
- Not Available
- External Links
- KEGG Drug
- D02038
- ChemSpider
- 10949
- 34300
- ChEBI
- 131526
- ChEMBL
- CHEMBL2105894
- Wikipedia
- Potassium_carbonate
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count Not Available Withdrawn Treatment Gastroesophageal Reflux 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Powder Oral Liquid Topical 0.1 g/100mL Liquid Oral; Topical 0.1 g/100mL Liquid Topical 0.001 1/80mL Liquid Topical 0.001 1/450mL Spray Topical 0.08 g/80mL Powder, for solution Oral Liquid Topical 0.5 g/500mL Ointment Topical - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 303.0 mg/mL ALOGPS logP -0.49 ALOGPS logP 0.25 Chemaxon logS 0.34 ALOGPS pKa (Strongest Acidic) 6.05 Chemaxon Physiological Charge -1 Chemaxon Hydrogen Acceptor Count 3 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 63.19 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 31.17 m3·mol-1 Chemaxon Polarizability 3.52 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 106.401695 predictedDeepCCS 1.0 (2019) [M+H]+ 108.5876 predictedDeepCCS 1.0 (2019) [M+Na]+ 117.12391 predictedDeepCCS 1.0 (2019)
Drug created at January 19, 2018 22:56 / Updated at February 21, 2021 18:54